CLONIDINE HYDROCHLORIDE tablet

Pajjiż: Stati Uniti

Lingwa: Ingliż

Sors: NLM (National Library of Medicine)

Ingredjent attiv:

CLONIDINE HYDROCHLORIDE (UNII: W76I6XXF06) (CLONIDINE - UNII:MN3L5RMN02)

Disponibbli minn:

Apotheca, Inc

INN (Isem Internazzjonali):

CLONIDINE HYDROCHLORIDE

Kompożizzjoni:

CLONIDINE HYDROCHLORIDE 0.1 mg

Rotta amministrattiva:

ORAL

Tip ta 'preskrizzjoni:

PRESCRIPTION DRUG

Indikazzjonijiet terapewtiċi:

Clonidine hydrochloride tablets, USP are indicated in the treatment of hypertension. Clonidine hydrochloride tablets, USP may be employed alone or concomitantly with other antihypertensive agents. Clonidine hydrochloride tablets, USP should not be used in patients with known hypersensitivity to clonidine (see PRECAUTIONS )

Sommarju tal-prodott:

Clonidine Hydrochloride Tablets, USP are available as: 0.1 mg: light tan, oval, scored, convex, debossed "25" bisect "41" on one side and debossed "V" on the reverse side, supplied as follows: NDC: 12634-465-71  BOTTLE OF 30 NDC: 12634-465-60  BOTTLE OF 60 NDC: 12634-465-01  BOTTLE OF 100 NDC: 12634-465-18  BOTTLE OF 180 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container.

L-istatus ta 'awtorizzazzjoni:

Abbreviated New Drug Application

Karatteristiċi tal-prodott

CLONIDINE HYDROCHLORIDE- CLONIDINE HYDROCHLORIDE TABLET
APOTHECA, INC
----------
CLONIDINE HYDROCHLORIDE TABLET
DESCRITION
Clonidine hydrochloride, USP is a centrally acting alpha-agonist
hypotensive agent available as tablets
for oral administration in three dosage strengths: 0.1 mg, 0.2 mg and
0.3 mg. The 0.1 mg tablet is
equivalent to 0.087 mg of the free base.
The inactive ingredients are dibasic calcium phosphate, FD&C Yellow #6
aluminum lake, lactose
monohydrate, magnesium stearate, microcrystalline cellulose, sodium
lauryl sulfate, sodium starch
glycolate. The clonidine hydrochloride 0.1 mg tablet also contains
FD&C Blue #1 aluminum lake and
FD&C Red #40 aluminum lake.
Clonidine hydrochloride is an imidazoline derivative and exists as a
mesomeric compound. The
chemical name is 2-(2,6-dichlorophenylamino)-2-imidazoline
hydrochloride. The following is the
structural formula:
Clonidine hydrochloride is an odorless, bitter, white, crystalline
substance soluble in water and
alcohol.
CLINICAL PHARMACOLOGY
Clonidine stimulates alpha-adrenoreceptors in the brain stem. This
action results in reduced sympathetic
outflow from the central nervous system and in decreases in peripheral
resistance, renal vascular
resistance, heart rate, and blood pressure. Clonidine hydrochloride
tablets act relatively rapidly. The
patient's blood pressure declines within 30 to 60 minutes after an
oral dose, the maximum decrease
occurring within 2 to 4 hours. Renal blood flow and glomerular
filtration rate remain essentially
unchanged. Normal postural reflexes are intact; therefore, orthostatic
symptoms are mild and infrequent.
Acute studies with clonidine hydrochloride in humans have demonstrated
a moderate reduction (15% to
20%) of cardiac output in the supine position with no change in the
peripheral resistance: at a 45° tilt
there is a smaller reduction in cardiac output and a decrease of
peripheral resistance. During long-term
therapy, cardiac output tends to return to control values, while
peripheral resistance remains decreased.